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Abstract
Ngari, Bunyamwera, Ilesha, and Germiston viruses are among the mosquito-borne human 
pathogens in the Orthobunyavirus genus, family Bunyaviridae, associated with febrile illness. 
Although the four orthobunyaviruses have been isolated from mosquito and/or tick vectors 
sampled from different geographic regions in Kenya, little is known of human exposure in such 
areas. We conducted a serologic investigation to determine whether orthobunyaviruses commonly 
infect humans in Kenya. Orthobunyavirus-specific antibodies were detected by plaque reduction 
neutralization tests in 89 (25.8%) of 345 persons tested. Multivariable analysis revealed age and 
residence in northeastern Kenya as risk factors. Implementation of acute febrile illness 
surveillance in northeastern Kenya will help to detect such infections.
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Introduction
Bunyamwera virus (BUNV) and Ngari virus (NRIV) have recently been isolated from 
mosquitoes and ticks in northeastern Kenya (Blaney Jr et al. 2001, Lwande et al. 2013, 
Ochieng et al. 2013). Likewise, Ilesha virus (ILEV) and Germiston virus (GERV) have 
previously been isolated from mosquitoes in western Kenya ( Johnson et al. 1977). These 
viruses belong to the Orthobunyavirus genus of the family Bunyaviridae and possess a 
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tripartite, single-stranded, negative-sense RNA genome. Some members of the genus 
including these four viruses are known to cause disease in humans with varying pathological 
consequences (Karabatsos 1985).
Although orthobunyaviruses have been isolated from arthropod vectors during surveillance 
exercises in Kenya, no clear evidence exists for incidence of human infection in this region 
because diagnostic laboratories seldom test for these infections. Moreover, viruses of this 
genus comprise a neglected but potentially deadly group of viruses given their potential to 
undergo genetic reassortment with altered pathogenic manifestations, as evidenced by the 
recent outbreak of Schmallenberg virus in Europe that resulted in malformations in 
ruminants (Wisloff et al. 2014) and the emergence of NRIV in hemorrhagic fever outbreaks 
in East Africa (Gerrard et al. 2004, Briese et al. 2006). We investigated whether 
orthobunyaviruses commonly infect humans in three different regions of Kenya, as an 
indication of past clinical or subclinical infection.
Materials and Methods
The present study obtained specimens from an Integrated Response System for Emerging 
Infectious Diseases in East Africa, also known as the Arbovirus Incidence and Diversity 
(AVID) project. This project brought together a consortium of implementing institutions 
consisting of health, veterinary, wildlife, and vector experts to take an integrated approach to 
arbovirus surveillance and research. The main aim of the project is to improve the prediction 
and prevention of Rift Valley fever virus and other emerging arboviruses and to develop a 
model for response that could be expanded to other emerging diseases in the East African 
region. The project is interested in the discovery of both known and unknown viruses 
causing emerging infectious diseases. Serum samples were obtained from 345 febrile 
patients at three health facilities in Kenya between January, 2009, and April, 2012. 
Specimens were drawn from patients attending Sangailu Dispensary (n = 94) and Kotile 
Health Centre (n = 118), the main facilities that serve most of the inhabitants of Ijara 
subcounty of Garissa County in northeastern Kenya. Specimens were also drawn from the 
Mai Mahiu Health Centre (n = 133) in Naivasha, a subcounty within Nakuru County of the 
Rift Valley Province of Kenya, a region from which no isolations of these viruses have been 
made. Ethical approval was obtained from the Kenya Medical Research Institute, Kenya.
All sera were screened at a dilution of 1:20 by a plaque reduction neutralization test (PRNT) 
using BUNV (strain GSA/S4/11232), NRIV (strain TND/S1/19801), ILEV, and GERV 
(both obtained from the Centers for Disease Control and Prevention [CDC], Fort Collins, 
CO) as described (Blitvich et al. 2012). Reactive sera were titrated to determine the highest 
dilution neutralizing 90% or greater of the virus. For etiological diagnosis, the PRNT90 
antibody titer was required to be four-fold or more higher than that of the other virus tested.
Results
Neutralizing antibodies to any of the four orthobunyaviruses were detected in 89 (25.8%) of 
345 study participants. Thirty-three participants (9.6%) had neutralizing antibodies to more 
than one virus, with PRNT titers ranging from 20 to 640 and the majority of cross-
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neutralization between ILEV and BUNV (Table 1). These specimens were titrated and 
analyzed by comparative PRNT to identify the Orthobunyavirus responsible for 
seropositivity. Eight specimens were resolved, whereas 25 remained undetermined (Table 
1). The observed cross-neutralization may represent persons doubly infected years ago, and, 
as such, trace amounts of antibodies remaining were insufficient to yield a four-fold or more 
difference in titer between the implicated viruses. Alternatively, there could be other yet to 
be identified orthobunyaviruses circulating within the same region. Although we did not 
screen for Shokwe virus, previously isolated in Kenya, antibodies against the virus do not 
neutralize any of the viruses tested in the current study (Karabatsos 1985). Additionally, it is 
possible that some of the patients seropositive for NRIV may have been infected with Batai 
virus, although this virus has not been isolated in Kenya.
Logistic regression analysis showed that risk for infection increased significantly with age (p 
≤ 0.0001). The proportion of participants with neutralizing antibodies against 
orthobunyaviruses was significantly higher in Sangailu (52.1%) compared to Kotile (32.2%) 
(p < 0.0001), probably due to its close proximity to the Boni Forest National Reserve, 
whereas Naivasha had the lowest proportion (1.5%). There was no gender difference in the 
proportion of participants with neutralizing antibodies against orthobunyaviruses.
Discussion
We found that 25.8% of 345 participants in our study had evidence of Orthobunyavirus 
exposure. The proportion of neutralizing antibodies was higher in participants 15 year or 
older, indicating that exposure to these viruses may have occurred during the Rift Valley 
fever outbreak in 1997–1998, where NRIV was isolated from hemorrhagic cases (Gerrard et 
al. 2004). Neutralizing antibodies in participants younger than 10 years may indicate 
ongoing interepidemic transmission and need to be investigated further. The proportion of 
participants with neutralizing antibodies increased with age, suggesting endemicity of these 
viruses in northeastern Kenya. Differences in the proportion of participants with neutralizing 
antibodies between subcounties can be explained by differences in climatic conditions that 
may influence economic activities of residents. Pastoralism as a source of livelihood and the 
nomadic nature of inhabitants of northeastern Kenya may promote the spread of these 
viruses due to their close interaction with domestic animals and possible interaction of their 
animals with wild animals (which may be reservoirs of these viruses) during grazing 
(Lwande et al. 2012). Additionally, mosquito vectors associated with previous isolations of 
these viruses, including Aedes (Ae.) mcintoshi, Ae. tricholabis, Ae. ochraceus, Culex pipiens, 
Anopheles (An.) gambiae, An. phareoensis, Mansoni (Mn) africanus, and Mn. uniformis 
(Gonzalez and Georges 1988, Logan et al. 1991, Traorelamizana et al. 2001, Crabtree et al. 
2009), are abundant in northeastern Kenya (Lutomiah et al. 2013) and may likely be 
transmitters of these viruses. Additionally, we have previously determined that An. gambiae 
is a competent vector for Bunyamwera and Ngari viruses (Odhiambo et al. 2014).
All patients in the parent study sought care for unspecified fevers, but we could not 
determine whether any of these febrile illnesses resulted from infection by these viruses 
because there was no follow-up to obtain convalescent sample for determination of rise in 
antibody titer. Moreover, no immunoglobulin M (IgM)-capture enzyme-linked 
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immunosorbent assay (ELISA) for orthobunyavirus diagnosis exists. Additionally, we were 
unsuccessful in isolation of these viruses from reactive sera by inoculation of reactive sera 
on confluent Vero cells culture and by reverse transcription (RT)-PCR using 
Orthobunyavirus genus primers, suggesting that these are likely past infections. However, 
viremia in humans is known to be transient and of low magnitude, hence RT-PCR may be 
ineffective for detection of Orthobunyavirus RNA in serum specimens (Blitvich et al. 2012). 
Given our inability to include Shokwe and Batai viruses in our analysis due to biosecurity 
concerns, definitive, specific diagnosis is limited by a lack of comprehensive diversity in the 
panel of viruses that were used for PRNT.
Conclusion
The present study demonstrates serological evidence of Orthobunyavirus activity in the 
Sangailu and Kotile regions of Garissa County in northeastern Kenya, thus requiring 
inclusion of orthobunyaviruses among the unrecognized causes of illness in humans within 
the region.
Acknowledgments
We acknowledge the technical assistance provided by Edith Chepkorir, Albina Makio, Hellen Koka, and Samuel 
Owaka, all of the Kenya Medical Research Institute. We also acknowledge the logistic support of Lillian Igweta, 
Lisa Omondi, and Margaret Ochanda, all of Capacity Building ICIPE—African Insect Science for Food and Health. 
This study was made possible through the financial support provided for by Swedish International Development 
Coorporation Agency (SIDA) through the African Regional Postgraduate Program in Insect Science of ICIPE 
whom we also wish to thank.
References
Blaney JE Jr, Johnson DH, Firestone CY, Hanson CT, et al. Chemical mutagenesis of dengue virus 
type 4 yields mutant viruses which are temperature sensitive in Vero cells or human liver cells and 
attenuated in mice. J Virol. 2001; 75:9731–9740. [PubMed: 11559806] 
Blitvich BJ, Saiyasombat R, Talavera-Aguilar LG, Garcia-Rejon JE, et al. Orthobunyavirus antibodies 
in humans, Yucatan Peninsula, Mexico. Emerg Infect Dis. 2012; 18:1629–1632. [PubMed: 
23017592] 
Briese T, Bird B, Kapoor V, Nichol ST, et al. Batai and Ngari viruses: M segment reassortment and 
association with severe febrile disease outbreaks in East Africa. J Virol. 2006; 80:5627–5630. 
[PubMed: 16699043] 
Crabtree M, Sang R, Lutomiah J, Richardson J, et al. Arbovirus surveillance of mosquitoes collected at 
sites of active Rift Valley Fever virus transmission: Kenya, 2006–2007. J Med Entomol. 2009; 
46:961–964. [PubMed: 19658258] 
Gerrard SR, Li L, Barrett AD, Nichol ST. Ngari virus is a Bunyamwera virus reassortant that can be 
associated with large outbreaks of hemorrhagic fever in Africa. J Virol. 2004; 78:8922–8926. 
[PubMed: 15280501] 
Gonzalez, JP.; Georges, AJ. Bunyaviral fevers: Bunyamwera, Ilesha, Germiston, Bwamba and 
Tataguine. In: Monath, T., editor. The Arboviruses: Epidemiology and Ecology. Boca Raton, FL: 
CRC Press; 1988. 
Johnson BK, Shockley P, Chanas AC, Squires EJ, et al. Arbovirus isolations from mosquitoes: Kano 
Plain, Kenya. Trans R Soc Trop Med Hyg. 1977; 71:518–521. [PubMed: 24288] 
Karabatsos N. Supplement to international catalogue of arboviruses including certain other viruses of 
vertebrates. Am J Trop Medicine Hyg. 1978; 27(2 Pt 2 Suppl):372.
Odhiambo et al. Page 4













Logan TM, Linthicum KJ, Davies FG, Binepal YS, et al. Isolation of Rift Valley fever virus from 
mosquitoes (Diptera: Culicidae) collected during an outbreak in domestic animals in Kenya. J Med 
Entomol. 1991; 28:293–295. [PubMed: 1676073] 
Lutomiah J, Bast J, Clark J, Richardson J, et al. Abundance, diversity, and distribution of mosquito 
vectors in selected ecological regions of Kenya: Public health implications. J Vector Ecol. 2013; 
38:134–142. [PubMed: 23701618] 
Lwande OW, Irura Z, Tigoi C, Chepkorir E, et al. Sero-prevalence of Crimean Congo hemorrhagic 
fever virus in Ijara District, Kenya. Vector Borne Zoonotic Dis. 2012; 12:727–732. [PubMed: 
22925021] 
Lwande OW, Lutomiah J, Obanda V, Gakuya F, et al. Isolation of tick and mosquito-borne arboviruses 
from ticks sampled from livestock and wild animal hosts in Ijara District, Kenya. Vector Borne 
Zoonotic Dis. 2013; 13:637–642. [PubMed: 23805790] 
Ochieng C, Lutomiah J, Makio A, Koka H, et al. Mosquito-borne arbovirus surveillance at selected 
sites in diverse ecological zones of Kenya; 2007–2012. Virol J. 2013; 10:140. [PubMed: 
23663381] 
Odhiambo C, Venter M, Chepkorir E, Mbaika S, et al. Vector competence of selected mosquito 
species in kenya for Ngari and Bunyamwera viruses. J Med Entomol. 2014; 51:1248–1253. 
[PubMed: 26309314] 
Traore-lamizana M, Fontenille D, Diallo M, Ba Y, et al. Arbovirus surveillance from 1990 to 1995 in 
the Barkedji area (Ferlo) of Senegal, a possible natural focus of Rift Valley Fever virus. J Med 
Entomol. 2001; 38:480–492. [PubMed: 11476327] 
Wisloff H, Nordvik BS, Sviland S, Tonnessen R. First documented clinical case of Schmallenberg 
virus in Norway: Fetal malformations in a calf. Vet Rec. 2014; 174:120. [PubMed: 24399664] 
Odhiambo et al. Page 5































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Vector Borne Zoonotic Dis. Author manuscript; available in PMC 2016 May 01.
